Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats

Frontiers in Behavioral Neuroscience

Volumn 8, Issue , 2014, Pages

  Tucci, Paolo ^a   Mhillaj, Emanuela ^a   Morgese, Maria Grazia ^a   Colaianna, Marilena ^b   Zotti, Margherita ^a   Schiavone, Stefania ^c   Cicerale, Maria ^a   Trezza, Viviana ^d   Campolongo, Patrizia ^e   Cuomo, Vincenzo ^e   Trabace, Luigia ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d ROMA TRE UNIVERSITY   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Glutamate; Long term memory; Memantine; Short term memory; Soluble beta amyloid

Indexed keywords

AMYLOID BETA PROTEIN; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LONG TERM MEMORY; MALE; MEMORY CONSOLIDATION; MICRODIALYSIS; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PREFRONTAL CORTEX; RAT; SHORT TERM MEMORY; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 84907294208     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00332     Document Type: Article

References (73)

1. Akirav, I., and Maroun, M. (2006). Ventromedial prefrontal cortex is obligatory for consolidation and reconsolidation of object recognition memory. Cereb. Cortex 16, 1759-1765. doi: 10.1093/cercor/bhj114
2. Arendt, T. (2009). Synaptic degeneration in Alzheimer’s disease. Acta Neuropathol. 118, 167-179. doi: 10.1007/s00401-009-0536-x
3. Arias, C., Arrieta, I., and Tapia, R. (1995). Beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J. Neurosci. Res. 41, 561-566. doi: 10.1002/jnr.490410416
4. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., et al. (2010). Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U S A 107, 2295-2300. doi: 10.1073/pnas.0911829107
5. Berg, L., Mckeel, D. W. Jr., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., et al. (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer’s disease: relation of histologic markers to dementia severity, age, sex and apolipoprotein E genotype. Arch. Neurol. 55, 326-335. doi: 10.1001/archneur.55.3.326
6. Blennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., and Davidsson, P. (1996). Synaptic pathology in Alzheimer’s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J. Neural Transm. 103, 603-618. doi: 10.1007/bf01273157
7. Bobich, J. A., Zheng, Q., and Campbell, A. (2004). Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release. J. Alzheimers Dis. 6, 243-255.
8. Campagna, F., Catto, M., Purgatorio, R., Altomare, C. D., Carotti, A., De Stradis, A., et al. (2011). Synthesis and biophysical evaluation of arylhydrazono-1H-2-indolinones as beta-amyloid aggregation inhibitors. Eur. J. Med. Chem. 46, 275-284. doi: 10.1016/j.ejmech.2010.11.015
9. Canas, P. M., Simões, A. P., Rodrigues, R. J., and Cunha, R. A. (2014). Predominant loss of glutamatergic terminal markers in a beta-amyloid peptide model of Alzheimer’s disease. Neuropharmacology 76(Pt. A), 51-56. doi: 10.1016/j.neuropharm.2013.08.026
10. Chin, J. H., Ma, L., Mactavish, D., and Jhamandas, J. H. (2007). Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors. J. Neurosci. 27, 9262-9269. doi: 10.1523/JNEUROSCI.1843-07.2007
11. Christensen, D. Z., Kraus, S. L., Flohr, A., Cotel, M. C., Wirths, O., and Bayer, T. A. (2008). Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathol. 116, 647-655. doi: 10.1007/s00401-008-0451-6
12. Clarke, J. R., Cammarota, M., Gruart, A., Izquierdo, I., and Delgado-Garcia, J. M. (2010). Plastic modifications induced by object recognition memory processing. Proc. Natl. Acad. Sci. U S A 107, 2652-2657. doi: 10.1073/pnas.0915059107
13. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., et al. (2005). Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84. doi: 10.1038/nn1372
14. Colaianna, M., Tucci, P., Zotti, M., Morgese, M. G., Schiavone, S., Govoni, S., et al. (2010). Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br. J. Pharmacol. 159, 1704-1715. doi: 10.1111/j.1476-5381.2010.00669.x
15. Cowburn, R. F., Wiehager, B., Trief, E., Li-Li, M., and Sundström, E. (1997). Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor. Neurochem. Res. 22, 1437-1442. doi: 10.1023/A:1021942109490
16. Danysz, W., and Parsons, C. G. (2003). The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int. J. Geriatr. Psychiatry 18, S23-S32. doi: 10.1002/gps.938
17. Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., and Quack, G. (1997). Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies. Neurosci. Biobehav. Rev. 21, 455-468. doi: 10. 1016/s0149-7634(96)00037-1
18. De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., et al. (2007). Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590-11601. doi: 10.1074/jbc.m607483200
19. Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., et al. (2009). Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol. Aging 30, 241-256. doi: 10.1016/j.neurobiolaging.2007.06.011
20. Dornan, W. A., Kang, D. E., Mccampbell, A., and Kang, E. E. (1993). Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat. Neuroreport 5, 165-168. doi: 10.1097/00001756-199311180-00018
21. Ennaceur, A., and Delacour, J. (1988). A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 31, 47-59. doi: 10.1016/0166-4328(88)90157-x
22. Ferreira, S. T., and Klein, W. L. (2011). The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease. Neurobiol. Learn. Mem. 96, 529-543. doi: 10.1016/j.nlm.2011.08.003
23. Giannakopoulos, P., Herrmann, F. R., Bussiere, T., Bouras, C., Kovari, E., Perl, D. P., et al. (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60, 1495-1500. doi: 10.1212/01.wnl.0000063311.58879.01
24. Giannakopoulos, P., Kövari, E., Gold, G., Von Gunten, A., Hof, P. R., and Bouras, C. (2009). Pathological substrates of cognitive decline in Alzheimer’s disease. Front. Neurol. Neurosci. 24, 20-29. doi: 10.1159/000197881
25. Giustino, A., Beckett, S., Ballard, T., Cuomo, V., and Marsden, C. A. (1996). Perinatal cocaine reduces responsiveness to cocaine and causes alterations in exploratory behavior and visual discrimination in young-adult rats. Brain Res. 728, 149-156. doi: 10.1016/s0006-8993(96)00229-6
26. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112. doi: 10.1038/nrm2101
27. Hasegawa, T. (2007). Prolonged stress will induce Alzheimer’s disease in elderly people by increased release of homocysteic acid. Med. Hypotheses 69, 1135-1139. doi: 10.1016/j.mehy.2007.02.034
28. Ikonomidou, C., and Turski, L. (2002). Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386. doi: 10.1016/s1474-4422(02)00164-3
29. Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., and Selkoe, D. J. (2011). Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. U S A 108, 5819-5824. doi: 10.1073/pnas.1017033108
30. Kabogo, D., Rauw, G., Amritraj, A., Baker, G., and Kar, S. (2010). SS-amyloidrelated peptides potentiate K+-evoked glutamate release from adult rat hip-pocampal slices. Neurobiol. Aging 31, 1164-1172. doi: 10.1016/j.neurobiolaging.2008.08.009
31. Kandel, E. R., Dudai, Y., and Mayford, M. R. (2014). The molecular and systems biology of memory. Cell 157, 163-186. doi: 10.1016/j.cell.2014.03.001
32. Kelly, B. L., and Ferreira, A. (2006). Beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J. Biol. Chem. 281, 28079-28089. doi: 10.1074/jbc.m605081200
33. Klyubin, I., Betts, V., Welzel, A. T., Blennow, K., Zetterberg, H., Wallin, A., et al. (2008). Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J. Neurosci. 28, 4231-4237. doi: 10.1523/JNEUROSCI.5161-07.2008
34. Kowalewski, T., and Holtzman, D. M. (1999). In situ atomic force microscopy study of Alzheimer’s beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc. Natl. Acad. Sci. U S A 96, 3688-3693. doi: 10.1073/pnas.96.7.3688
35. Lacor, P. N., Buniel, M. C., Furlow, P. W., Clemente, A. S., Velasco, P. T., Wood, M., et al. (2007). Abeta oligomer-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J. Neurosci. 27, 796-807. doi: 10.1523/jneurosci.3501-06. 2007
36. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., et al. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U S A 95, 6448-6453. doi: 10.1073/pnas.95.11.6448
37. Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., et al. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357. doi: 10.1038/nature04533
38. Lipton, S. A. (2007). Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr. Drug Targets 8, 621-632. doi: 10.2174/138945007780618472
39. Lopez-Ramos, J. C., Jurado-Parras, M. T., Sanfeliu, C., Acuna-Castroviejo, D., and Delgado-Garcia, J. M. (2012). Learning capabilities and CA1-prefrontal synaptic plasticity in a mice model of accelerated senescence. Neurobiol. Aging 33, 627.e13-627.e26. doi: 10.1016/j.neurobiolaging.2011.04.005
40. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., et al. (1999). Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am. J. Pathol. 155, 853-862. doi: 10.1016/s0002-9440(10)65184-x
41. Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., and Kivipelto, M. (2010). Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 9, 702-716. doi: 10.1016/S1474-4422(10)70119-8
42. Markowitsch, H. J., and Staniloiu, A. (2012). Amnesic disorders. Lancet 380, 1429-1440. doi: 10.1016/S0140-6736(11)61304-4
43. Martinez-Coria, H., Green, K. N., Billings, L. M., Kitazawa, M., Albrecht, M., Rammes, G., et al. (2010). Memantine improves cognition and reduces Alzheimer’s-like neuropathology in transgenic mice. Am. J. Pathol. 176, 870-880. doi: 10.2353/ajpath.2010.090452
44. Mayford, M., Siegelbaum, S. A., and Kandel, E. R. (2012). Synapses and memory storage. Cold Spring Harb. Perspect. Biol. 4:a005751. doi: 10.1101/cshperspect.a005751
45. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., et al. (1999). Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann. Neurol. 46, 860-866. doi: 10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0. co;2-m
46. Misztal, M., Frankiewicz, T., Parsons, C. G., and Danysz, W. (1996). Learning deficits induced by chronic intraventricular infusion of quinolinic acid-protection by MK-801 and memantine. Eur. J. Pharmacol. 296, 1-8. doi: 10.1016/0014-2999(95)00682-6
47. Molnár, Z., Soós, K., Lengyel, I., Penke, B., Szegedi, V., and Budai, D. (2004). Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. Neuroreport 15, 1649-1652. doi: 10.1097/01.wnr.0000134471.06244.d2
48. Morgese, M. G., Tucci, P., Colaianna, M., Zotti, M., Cuomo, V., Schiavone, S., et al. (2014). Modulatory activity of soluble beta amyloid on HPA axis function in rats. Curr. Pharm. Des. 20, 2539-2546. doi: 10.2174/13816128113199990500
49. Mucke, L., and Selkoe, D. J. (2012). Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2:a006338. doi: 10.1101/cshperspect.a006338
50. Nakamura, S., Murayama, N., Noshita, T., Katsuragi, R., and Ohno, T. (2006). Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801. Eur. J. Pharmacol. 548, 115-122. doi: 10.1016/j.ejphar.2006.07.049
51. Noda, M., Nakanishi, H., and Akaike, N. (1999). Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 1465-1474. doi: 10.1016/s0306-4522(99)00036-6
52. Parsons, C. G., and Gilling, K. (2007). Memantine as an example of a fast, voltagedependent, open channel N-methyl-D-aspartate receptor blocker. Methods Mol. Biol. 403, 15-36. doi: 10.1007/978-1-59745-529-9_2
53. Parsons, C. G., Stoffler, A., and Danysz, W. (2007). Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 53, 699-723. doi: 10.1016/j.neuropharm.2007.07.013
54. Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
55. Peskind, E. R., Potkin, S. G., Pomara, N., Ott, B. R., Graham, S. M., Olin, J. T., et al. (2006). Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am. J. Geriatr. Psychiatry 14, 704-715. doi: 10.1097/01.JGP.0000224350.82719.83
56. Poling, A., Morgan-Paisley, K., Panos, J. J., Kim, E. M., O’hare, E., Cleary, J. P., et al. (2008). Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures. Behav. Brain Res. 193, 230-234. doi: 10.1016/j.bbr.2008.06.001
57. Puoliväli, J., Wang, J., Heikkinen, T., Heikkilä, M., Tapiola, T., Van Groen, T., et al. (2002). Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol. Dis. 9, 339-347. doi: 10.1006/nbdi.2002.0481
58. Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., et al. (2008). Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545. doi: 10.1523/jneurosci.2692-08.2008
59. Ragozzino, M. E., Detrick, S., and Kesner, R. P. (2002). The effects of prelimbic and infralimbic lesions on working memory for visual objects in rats. Neurobiol. Learn. Mem. 77, 29-43. doi: 10.1006/nlme.2001.4003
60. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., et al. (2008). Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842. doi: 10.1038/nm1782
61. Sokolow, S., Henkins, K. M., Bilousova, T., Miller, C. A., Vinters, H. V., Poon, W., et al. (2012). AD synapses contain abundant Abeta monomer and multiple soluble oligomers, including a 56-kDa assembly. Neurobiol. Aging 33, 1545-1555. doi: 10.1016/j.neurobiolaging.2011.05.011
62. Taglialatela, G., Hogan, D., Zhang, W. R., and Dineley, K. T. (2009). Intermediateand long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav. Brain Res. 200, 95-99. doi: 10.1016/j.bbr.2008.12.034
63. Texidó, L., Martin-Satué, M., Alberdi, E., Solsona, C., and Matute, C. (2011). Amyloid beta peptide oligomers directly activate NMDA receptors. Cell Calcium 49, 184-190. doi: 10.1016/j.ceca.2011.02.001
64. Trabace, L., Kendrick, K. M., Castrignanò, S., Colaianna, M., De Giorgi, A., Schiavone, S., et al. (2007). Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide. Neuroscience 147, 652-663. doi: 10.1016/j.neuroscience.2007.04.056
65. Watanabe, T., Yamagata, N., Takasaki, K., Sano, K., Hayakawa, K., Katsurabayashi, S., et al. (2009). Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer’s disease. Brain Res. 1249, 222-228. doi: 10.1016/j.brainres.2008.10.029
66. Weiner, M. W., Veitch, D. P., Hayes, J., Neylan, T., Grafman, J., Aisen, P. S., et al. (2014). Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer’s disease in veterans, using the Alzheimer’s disease neuroimaging initiative. Alzheimers Dement. 10, S226-S235. doi: 10.1016/j.jalz.2014.04.005
67. Wilcox, K. C., Lacor, P. N., Pitt, J., and Klein, W. L. (2011). Abeta oligomer-induced synapse degeneration in Alzheimer’s disease. Cell. Mol. Neurobiol. 31, 939-948. doi: 10.1007/s10571-011-9691-4
68. Wiltfang, J., Smirnov, A., Schnierstein, B., Kelemen, G., Matthies, U., Klafki, H. W., et al. (1997). Improved electrophoretic separation and immunoblotting of betaamyloid (A beta) peptides 1-40, 1-42 and 1-43. Electrophoresis 18, 527-532. doi: 10.1002/elps.1150180332
69. Xia, P., Chen, H. S., Zhang, D., and Lipton, S. A. (2010). Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30, 11246-11250. doi: 10.1523/jneurosci.2488-10.2010
70. Xiang, J. Z., and Brown, M. W. (2004). Neuronal responses related to long-term recognition memory processes in prefrontal cortex. Neuron 42, 817-829. doi: 10.1016/j.neuron.2004.05.013
71. Yu, L., Edalji, R., Harlan, J. E., Holzman, T. F., Lopez, A. P., Labkovsky, B., et al. (2009). Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48, 1870-1877. doi: 10.1021/bi802046n
72. Zhang, W., Bai, M., Xi, Y., Hao, J., Liu, L., Mao, N., et al. (2012). Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction. Free Radic. Biol. Med. 52, 1443-1452. doi: 10.1016/j.freeradbiomed.2012.01.023
73. Zoladz, P. R., Campbell, A. M., Park, C. R., Schaefer, D., Danysz, W., and Diamond, D. M. (2006). Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol. Biochem. Behav. 85, 298-306. doi: 10.1016/j.pbb.2006.08.011